BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 28233861)

  • 1. Ubiquitin-specific peptidase 48 regulates Mdm2 protein levels independent of its deubiquitinase activity.
    Cetkovská K; Šustová H; Uldrijan S
    Sci Rep; 2017 Feb; 7():43180. PubMed ID: 28233861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CSN-associated USP48 confers stability to nuclear NF-κB/RelA by trimming K48-linked Ub-chains.
    Schweitzer K; Naumann M
    Biochim Biophys Acta; 2015 Feb; 1853(2):453-69. PubMed ID: 25486460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acetylation-dependent regulation of MDM2 E3 ligase activity dictates its oncogenic function.
    Nihira NT; Ogura K; Shimizu K; North BJ; Zhang J; Gao D; Inuzuka H; Wei W
    Sci Signal; 2017 Feb; 10(466):. PubMed ID: 28196907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNF12 promotes p53-dependent cell growth suppression and apoptosis by targeting MDM2 for destruction.
    Gao K; Wang C; Jin X; Xiao J; Zhang E; Yang X; Wang D; Huang H; Yu L; Zhang P
    Cancer Lett; 2016 May; 375(1):133-141. PubMed ID: 26926424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus nuclear antigen 3C augments Mdm2-mediated p53 ubiquitination and degradation by deubiquitinating Mdm2.
    Saha A; Murakami M; Kumar P; Bajaj B; Sims K; Robertson ES
    J Virol; 2009 May; 83(9):4652-69. PubMed ID: 19244339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The nucleolar SUMO-specific protease SMT3IP1/SENP3 attenuates Mdm2-mediated p53 ubiquitination and degradation.
    Nishida T; Yamada Y
    Biochem Biophys Res Commun; 2011 Mar; 406(2):285-91. PubMed ID: 21316347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovarian tumor domain-containing protein 1 deubiquitinates and stabilizes p53.
    Piao S; Pei HZ; Huang B; Baek SH
    Cell Signal; 2017 May; 33():22-29. PubMed ID: 28216291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. USP3 stabilizes p53 protein through its deubiquitinase activity.
    Fu S; Shao S; Wang L; Liu H; Hou H; Wang Y; Wang H; Huang X; Lv R
    Biochem Biophys Res Commun; 2017 Oct; 492(2):178-183. PubMed ID: 28807825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HAUSP-nucleolin interaction is regulated by p53-Mdm2 complex in response to DNA damage response.
    Lim KH; Park JJ; Gu BH; Kim JO; Park SG; Baek KH
    Sci Rep; 2015 Aug; 5():12793. PubMed ID: 26238070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of Mdm2 and MdmX fusion proteins alters p53 mediated transactivation, ubiquitination, and degradation.
    Ghosh M; Huang K; Berberich SJ
    Biochemistry; 2003 Mar; 42(8):2291-9. PubMed ID: 12600196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TRIAD1 inhibits MDM2-mediated p53 ubiquitination and degradation.
    Bae S; Jung JH; Kim K; An IS; Kim SY; Lee JH; Park IC; Jin YW; Lee SJ; An S
    FEBS Lett; 2012 Sep; 586(19):3057-63. PubMed ID: 22819825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The deubiquitinating enzyme USP48 stabilizes TRAF2 and reduces E-cadherin-mediated adherens junctions.
    Li S; Wang D; Zhao J; Weathington NM; Shang D; Zhao Y
    FASEB J; 2018 Jan; 32(1):230-242. PubMed ID: 28874458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SUMO-specific protease SUSP4 positively regulates p53 by promoting Mdm2 self-ubiquitination.
    Lee MH; Lee SW; Lee EJ; Choi SJ; Chung SS; Lee JI; Cho JM; Seol JH; Baek SH; Kim KI; Chiba T; Tanaka K; Bang OS; Chung CH
    Nat Cell Biol; 2006 Dec; 8(12):1424-31. PubMed ID: 17086174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The oncoprotein SS18-SSX1 promotes p53 ubiquitination and degradation by enhancing HDM2 stability.
    D'Arcy P; Maruwge W; Ryan BA; Brodin B
    Mol Cancer Res; 2008 Jan; 6(1):127-38. PubMed ID: 18234968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MDM2 mediates ubiquitination and degradation of activating transcription factor 3.
    Mo P; Wang H; Lu H; Boyd DD; Yan C
    J Biol Chem; 2010 Aug; 285(35):26908-26915. PubMed ID: 20592017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mdm2 promotes Cdc25C protein degradation and delays cell cycle progression through the G2/M phase.
    Giono LE; Resnick-Silverman L; Carvajal LA; St Clair S; Manfredi JJ
    Oncogene; 2017 Dec; 36(49):6762-6773. PubMed ID: 28806397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical role for Daxx in regulating Mdm2.
    Tang J; Qu LK; Zhang J; Wang W; Michaelson JS; Degenhardt YY; El-Deiry WS; Yang X
    Nat Cell Biol; 2006 Aug; 8(8):855-62. PubMed ID: 16845383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinoblastoma protein modulates gankyrin-MDM2 in regulation of p53 stability and chemosensitivity in cancer cells.
    Qiu W; Wu J; Walsh EM; Zhang Y; Chen CY; Fujita J; Xiao ZX
    Oncogene; 2008 Jul; 27(29):4034-43. PubMed ID: 18332869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. UBTD1 induces cellular senescence through an UBTD1-Mdm2/p53 positive feedback loop.
    Zhang XW; Wang XF; Ni SJ; Qin W; Zhao LQ; Hua RX; Lu YW; Li J; Dimri GP; Guo WJ
    J Pathol; 2015 Mar; 235(4):656-67. PubMed ID: 25382750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HAUSP, a novel deubiquitinase for Rb - MDM2 the critical regulator.
    Bhattacharya S; Ghosh MK
    FEBS J; 2014 Jul; 281(13):3061-78. PubMed ID: 24823443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.